PMID: 11898588Mar 20, 2002Paper

Advances in myasthenia gravis

Current Neurology and Neuroscience Reports
E Ciafaloni, D B Sanders

Abstract

Recent advances in the diagnosis and treatment of acquired myasthenia gravis (MG) are reviewed. Increased awareness about the need for more uniform methods of reporting treatment trials for MG has prompted systematic review of the literature and inspired an effort to develop better classifications and disease-specific outcome measures. New antibodies have been discovered in patients with seronegative MG, possibly defining an immunologically distinct form of the disease. A new immunosuppressant, mycophenolate mofetil, may be an additional and safe option in the treatment of MG. Other work supports the possibility of developing a vaccine against MG suitable for trial in humans.

References

Dec 1, 1987·Journal of the American Academy of Dermatology·W W EpinetteM C Greist
Mar 1, 1984·Annals of Neurology·R M PascuzziT R Johns
Apr 1, 1993·Electroencephalography and Clinical Neurophysiology·F E Somnier, W Trojaborg
Nov 16, 1996·Lancet·J J Lipsky
Feb 1, 1997·Journal of Autoimmunity·H YoshikawaM Takamori
Jul 21, 1998·Annals of the New York Academy of Sciences·R J BarohnW W Bryan
Jan 29, 1999·Archives of Neurology·J A Aarli
May 5, 1999·Neurology·G I WolfeR J Barohn
Jul 16, 1999·Ophthalmology·K C GolnikE R Eggenberger
Aug 24, 1999·Muscle & Nerve·D H WeinbergJ J Kelly
Oct 3, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·E LetkoA R Ahmed
Jan 8, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S AragaJ E Blalock
Mar 17, 2000·Neurology·K PoulasS J Tzartos
Aug 3, 2000·Muscle & Nerve·M N Meriggioli, J Rowin
Aug 10, 2000·Neurology·E CiafaloniD B Sanders
Jan 10, 2001·Neurology·E CiafaloniD B Sanders
Mar 27, 2001·Muscle & Nerve·R H PaulJ M Goldstein
May 23, 2001·Experimental Biology and Medicine·J L McAnallyJ E Blalock
May 30, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·G PavesiD Mancia

❮ Previous
Next ❯

Citations

Jul 8, 2005·Thoracic Surgery Clinics·Kemp H Kernstine
Oct 2, 2007·Clinical Neurology and Neurosurgery·Naoki KawaguchiTakamichi Hattori
Jun 1, 2007·Autoimmunity Reviews·Mario García-CarrascoRicard Cervera
Sep 29, 2004·Journal of the Neurological Sciences·Naoki KawaguchiUNKNOWN Study Group for Myasthenia Gravis in Japan
Sep 15, 2011·Journal of Clinical Apheresis·Kelly GwathmeyTed Burns
Apr 24, 2012·Journal of Clinical Apheresis·Kelly GwathmeyTed Burns
Jan 1, 2003·Current Neurology and Neuroscience Reports·Michio Hirano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
B Ferrero, L Durelli
© 2022 Meta ULC. All rights reserved